PT Medikaloka Hermina (HEAL) investor relations material

Executive summary

• Operates 53 hospitals with 9,019 beds and over 3,700 doctors as of June 30, 2026, making it the largest listed hospital group in Indonesia.

• Net revenues for the six months ended June 30, 2026, reached Rp3,609,409 million, up 6.5% year-over-year from Rp3,388,561 million in 2025.

• Net income for the period was Rp249,026 million, a decrease from Rp284,308 million in the prior year.

• Maintains a unique doctor partnership model, aligning clinical and business goals to attract and retain top talent.

• Focuses on women and children care, while expanding advanced specialties and Centers of Excellence.

Financial highlights

• Total revenue for 6M26 reached IDR 3,609 billion, up 6.5% year-over-year; EBITDA grew 0.1% to IDR 1,192 billion (35.2% margin).

• Gross profit for the period was Rp1,236,162 million, up from Rp1,191,768 million year-over-year.

• PAT and PATMI declined by 12.2% and 13.8%, respectively; earnings per share was Rp12.62, down from Rp15.11.

• Inpatient revenue rose 11.6% and outpatient revenue grew 1.9% year-over-year for 6M26.

• Cash and bank balances at period end were Rp571,787 million as of June 30, 2026.

Outlook and guidance

• Plans to roll out six new Centers of Excellence in oncology, cardiac care, stroke, fertility, orthopedics, and uro-nephrology.

• Pipeline includes greenfield hospital development in Kepanjen (100 beds, opening 3Q26) and brownfield expansions in Lampung, Arcamanik, and Bogor.

• Hospital management services (PT MLM) are expanding as a profit center, serving both internal and external hospitals.

• Management continues to focus on maintaining healthy capital structure and compliance with loan covenants.

• The Group plans to increase share capital to support future liquidity and growth.